Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

A disastrous sequela of a missed ureteric stent.

Yang PK, Agarwal D, Corcoran N.

Med J Aust. 2009 Nov 16;191(10):567-8. No abstract available.

PMID:
19912092
2.

[Ultrasonically guided percutaneous nephrostomy--indications and technic].

Knönagel H, Jaeger P, Hauri D.

Schweiz Rundsch Med Prax. 1988 Feb 23;77(8):176-81. German. No abstract available.

PMID:
3282297
3.

The undoing of ureteral obstruction from malignancy-who and how?

Wolf JS Jr.

J Urol. 2008 Aug;180(2):435-6. doi: 10.1016/j.juro.2008.05.037. Epub 2008 Jun 11. No abstract available.

PMID:
18550096
4.

[Tumors of the upper excretory urinary tract, calices, renal pelvis and ureter].

Mazeman E.

J Urol Nephrol (Paris). 1972 Oct;78:Suppl 9:1-219. French. No abstract available.

PMID:
4665217
5.

Renal pelvic and ureteral carcinoma with huge hydronephrosis: US, CT, and MR findings.

Kanematsu M, Hoshi H, Imaeda T, Yamawaki Y, Ueno K, Yasuda M, Kuriyama M, Shimokawa K.

Radiat Med. 1996 Nov-Dec;14(6):321-3.

PMID:
9132813
6.

[Improved tumor stent for internal palliative urinary diversion].

Schlick RW, Seidl E, Küster J, Kalem T, Hanke PR, Planz B.

Urologe A. 1999 Mar;38(2):138-42. German.

PMID:
10231934
7.

Lower ureteric obstruction: a complication of tailed ureteric stents.

Bultitude MF, Dasgupta P, Cynk M, Glass JM, Tiptaft RC.

BJU Int. 2003 Apr;91(6):581. No abstract available.

8.

Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.

Russo P.

J Urol. 2005 Dec;174(6):2088. No abstract available.

PMID:
16280733
9.

Ureteric stricture formation following ureteric instrumentation in patients with a nephrostomy drain in place.

O'Sullivan DC, Lemberger RJ, Bishop MC, Bates CP, Dunn M.

Br J Urol. 1994 Aug;74(2):165-9.

PMID:
7921932
11.

Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors.

Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN.

Urology. 2001 Oct;58(4):526-31.

PMID:
11597531
12.

Periureteral extension of prostatic carcinoma.

Bissada NK, Bell RA, Redman JF.

Urology. 1975 Apr;5(4):514-6. No abstract available.

PMID:
1129869
13.

Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results.

Tekin MI, Aytekin C, Aygün C, PeSkircioğlu L, Boyvat F, Ozkardeş H.

Urology. 2001 Dec;58(6):919-23.

PMID:
11744459
14.
15.

Management of encrusted ureteral stents impacted in upper tract.

Bultitude MF, Tiptaft RC, Glass JM, Dasgupta P.

Urology. 2003 Oct;62(4):622-6. Review.

PMID:
14550429
16.

Upper urinary tract cancer--challenges for the urologist.

Bostrom PJ, Soloway MS.

J Urol. 2007 Jul;178(1):12-3. Epub 2007 May 11. No abstract available.

PMID:
17574051
17.

Percutaneous antegrade ureteric stent insertion in malignant disease.

Harding JR.

Clin Radiol. 1995 Jan;50(1):68. No abstract available.

PMID:
7834985
18.

The management of malignant ureteral obstruction treated with ureteral stents.

Ganatra AM, Loughlin KR.

J Urol. 2005 Dec;174(6):2125-8.

PMID:
16280741
19.

[Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].

Flam T, Géraud M, Zerbib M, Debré B, Steg A.

Ann Urol (Paris). 1990;24(6):530-2. French.

PMID:
1702963
20.

Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility.

Lennon GM, Thornhill JA, Grainger R, McDermott TE, Butler MR.

Eur Urol. 1997;31(1):24-9.

PMID:
9032530

Supplemental Content

Support Center